Document is current
Any future updates will be listed below
-
Authors
Hogg, Simon J.
Motorna, Olga
Kearney, Conor J.
Derrick, Emily B.
House, Imran G.
Todorovski, Izabela
Kelly, Madison J.
Zethoven, Magnus
Bromberg, Kenneth D.
Lai, Albert
Beavis, Paul A.
Shortt, Jake
Johnstone, Ricky W.
Vervoort, Stephin J.
- License Information
-
More Information
Article History
Received: 17 June 2022
Accepted: 14 July 2022
First Online: 28 July 2022
Declarations
:
: Not applicable.
: Not applicable.
: The Johnstone laboratory receives funding support from Roche, BMS, AstraZeneca and MecRx. R.W.J. is a shareholder and consultant for MecRx. S.J.H, A.L. and K.D.B. are employees of AbbVie and hold stocks in the company. S.J.H. and R.W.J. are inventors on a patent (WO2017059319A3) related to combining bromodomain inhibitors and immune-modulating therapies. All other authors declare no relevant competing interests.
